Vident Advisory’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$675K	Buy	24,098 +6,108	+34%	+$200K	0.01%	1077
2025 Q4	$673K	Sell	17,990 -267	-1%	-$8.78K	0.01%	991
2025 Q3	$503K	Buy	18,257 +2,968	+19%	+$102K	﹤0.01%	1202
2025 Q2	$483K	Sell	15,289 -59	-0.4%	-$1.9K	0.01%	1076
2025 Q1	$509K	Sell	15,348 -1,078	-7%	-$38.6K	0.01%	1022
2024 Q4	$565K	Buy	16,426 +2,493	+18%	+$85.7K	0.01%	880
2024 Q3	$557K	Sell	13,933 -7,365	-35%	-$259K	0.01%	870
2024 Q2	$643K	Buy	+21,298	New	+$640K	0.02%	772
2024 Q1	–	Sell	-6,312	Closed	-$204K	–	1361
2023 Q4	$204K	Sell	6,312 -5,529	-47%	-$154K	0.01%	1208
2023 Q3	$388K	Buy	+11,841	New	+$411K	0.01%	787